Salvatore R. Bombara v. HHS - Tdap, Guillain-Barré Syndrome (2020)
Case summary [AI summaries can sometimes make mistakes]
Salvatore R. Bombara filed a petition for compensation under the National Vaccine Injury Compensation Program on July 20, 2018.
Mr. Bombara alleged that he developed Guillain-Barré Syndrome (GBS) after receiving a tetanus, diphtheria, and acellular pertussis (Tdap) vaccination on February 14, 2017.
The respondent, the Secretary of Health and Human Services, denied that the immunization caused Mr. Bombara's injury.
Despite the respondent's denial, the parties reached a settlement agreement. On October 16, 2020, they filed a joint stipulation outlining the terms of the settlement.
As part of this agreement, the respondent agreed to issue a payment of $93,322.98 to Mr. Bombara as compensation for all available damages.
Special Master Mindy Michaels Roth adopted the stipulation and awarded the compensation, directing the clerk of the court to enter judgment accordingly. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses.
Petitioner counsel was Amy Senerth, Esq., of Muller Brazil, LLP, PA, and respondent counsel was Lisa Watts, Esq., of the US Department of Justice.
Theory of causation
Petitioner Salvatore R. Bombara alleged Guillain-Barré Syndrome (GBS) following a Tdap vaccination on February 14, 2017. Respondent denied causation. The parties reached a settlement, and a joint stipulation was filed on October 16, 2020. The settlement included a lump sum payment of $93,322.98 to the petitioner for all damages. Special Master Mindy Michaels Roth adopted the stipulation and awarded compensation. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury.
Source PDFs
USCOURTS-cofc-1_18-vv-01067